Cite
HARVARD Citation
Burt, R. et al. (2019). Blinatumomab, a bispecific B-cell and T-cell engaging antibody, in the treatment of B-cell malignancies. Human vaccines & immunotherapeutics. 15 (3), pp. 594-602. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Burt, R. et al. (2019). Blinatumomab, a bispecific B-cell and T-cell engaging antibody, in the treatment of B-cell malignancies. Human vaccines & immunotherapeutics. 15 (3), pp. 594-602. [Online].